XBiotech
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2005-01-01
- Employees
- 82
- Market Cap
- $198M
- Website
- http://www.xbiotech.com
- Introduction
XBiotech, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutic antibodies. Its product pipeline includes oncology, infectious diseases, dermatology and inflammatory disorders. The company was founded by John Simard on March 22, 2005 and is headquartered in Austin, TX.
XBiotech Halts Rheumatology Program Following Phase II Trial Irregularities with Natrunix
XBiotech has paused its rheumatology program after a Phase II trial of Natrunix for rheumatoid arthritis failed to meet its primary endpoint.
BioAge Labs Faces Securities Lawsuits Following Azelaprag Trial Discontinuation
BioAge Labs is under investigation for potential securities law violations after discontinuing its Phase 2 trial of azelaprag due to safety concerns.